Literature DB >> 16183094

Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs.

María Herrera1, Guillermo León, Alvaro Segura, Fabricio Meneses, Bruno Lomonte, Jean Philippe Chippaux, José María Gutiérrez.   

Abstract

Caprylic acid purification of IgG, currently used in the manufacture of horse-derived antivenoms, was successfully adapted for the preparation of sheep and camel IgG. Sheep IgG had a molecular mass of approximately 150 kDa, whereas camel IgG presented two bands of molecular masses of approximately 160 and 100 kDa, the latter corresponding to heavy-chain IgG, which is devoid of light chains. Horse, sheep and camel IgGs were compared by several parameters aiming at predicting their potential for induction of early and late adverse reactions. Horse and sheep IgGs showed a higher anticomplementary activity than camel IgG, and also elicited a higher anti-IgG response than camel IgG, when injected in mice. Horse IgG agglutinated human type O+ erythrocytes, whereas no such reactivity was observed in sheep and camel IgG preparations. A novel procedure was used for the detection of antibodies in human serum against animal IgGs. It was found that a pool of human sera collected in Costa Rica had a higher titer of antibodies directed against horse and sheep IgGs than against camel IgG. Overall, camel IgG showed the lowest potential for the induction of adverse reactions among the three IgGs tested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183094     DOI: 10.1016/j.toxicon.2005.08.004

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

1.  Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy.

Authors:  Sedigheh Khamehchian; Hossein Zolfagharian; Naser Mohammadpour Dounighi; Majid Tebianian; Rasool Madani
Journal:  Hum Vaccin Immunother       Date:  2014-03-18       Impact factor: 3.452

2.  Anticomplementary activity of horse IgG and F(ab')2 antivenoms.

Authors:  Carla Cristina Squaiella-Baptistão; José Roberto Marcelino; Luiz Eduardo Ribeiro da Cunha; José María Gutiérrez; Denise V Tambourgi
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

3.  Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology.

Authors:  Ali Nazari; Maedeh Samianifard; Hadi Rabie; Abbas Zare Mirakabadi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-06-19

Review 4.  Economic Evaluations of Interventions for Snakebites: A Systematic Review.

Authors:  Juan Carlos Quintana-Castillo; Sebastián Estrada-Gómez; Jaiberth Antonio Cardona-Arias
Journal:  Clinicoecon Outcomes Res       Date:  2020-09-18

Review 5.  From Desert to Medicine: A Review of Camel Genomics and Therapeutic Products.

Authors:  Amanat Ali; Bincy Baby; Ranjit Vijayan
Journal:  Front Genet       Date:  2019-02-19       Impact factor: 4.599

6.  Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2.

Authors:  Lotfi Chouchane; Jean-Charles Grivel; Elmoubasher Abu Baker Abd Farag; Igor Pavlovski; Selma Maacha; Abbirami Sathappan; Hamad Eid Al-Romaihi; Sirin Wj Abuaqel; Manar Mahmoud Ahmad Ata; Aouatef Ismail Chouchane; Sami Remadi; Najeeb Halabi; Arash Rafii; Mohammed H Al-Thani; Nico Marr; Murugan Subramanian; Jingxuan Shan
Journal:  JCI Insight       Date:  2021-03-08

7.  In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.

Authors:  Gabrielle Richard; Ashley J Meyers; Michael D McLean; Mehdi Arbabi-Ghahroudi; Roger MacKenzie; J Christopher Hall
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

Review 8.  Recent Advances in Next Generation Snakebite Antivenoms.

Authors:  Cecilie Knudsen; Andreas H Laustsen
Journal:  Trop Med Infect Dis       Date:  2018-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.